Skip to main navigation Skip to search Skip to main content

Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225: Cond Med

  • Ioannou Andreadou
  • , Pavle Adamovski
  • , Monika Bartekova
  • , Christophe Beauloye
  • , Luc Bertrand
  • , David Biedermann
  • , Vilmante Borutaite
  • , Hans Erik Bøtker
  • , Stefan Chlopicki
  • , Maija Dambrova
  • , Sean Davidson
  • , Yvan Devaux
  • , Fabio Di Lisa
  • , Dragan Djuric
  • , David Erlinge
  • , Inês Falcao-Pires
  • , Eleftheria Galatou
  • , David García-Dorado
  • , Alfonso T Garcia-Sosa
  • , Henrique Girão
  • Zoltan Giricz, Mariann Gyöngyösi, Donagh Healy, Gerd Heusch, Vladimir Jakovljevic, Jelena Jovanic, Frantisek Kolar, Brenda R Kwak, Przemyslaw Leszek, Edgars Liepinsh, Sarah Longnus, Jasna Marinovic, Danina Mirela Muntean, Lana Nezic, Michel Ovize, Pasquale Pagliaro, Clarissa Pedrosa da Costa Gomes, John Pernow, Andreas Persidis, Sören Erik Pischke, Bruno K Podesser, Fabrice Prunier, Tanya Ravingerova, Marisol Ruiz-Meana, Rainer Schulz, Alina Scridon, Katrine H Slagsvold, Jacob Thomsen Lønborg, Belma Turan, Niels van Royen, on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225: Cond Med'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science